PDS Biotechnology Corporation

NASDAQ:PDSB

1.39 (USD) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 56.56173.8265.24328.8412.16234.64688.068106.399130.18913.7297.8580.141
Short Term Investments 000000000000
Cash and Short Term Investments 56.56173.8265.24328.8412.16234.64688.068106.399130.18913.7297.8580.141
Net Receivables 00000000000.4590
Inventory 000000000000
Other Current Assets 2.4952.661.5981.4982.3081.0060.0510.1311.0811.6180.2130.006
Total Current Assets 59.05576.4866.8430.33714.4735.65189.054107.354131.27115.4428.530.147
Non-Current Assets:
Property, Plant & Equipment, Net 0.3350.5280.3580.5530.0210.4273.4243.4182.7671.4440.140.008
Goodwill 000000000000
Intangible Assets 0000000.0470.0520000
Goodwill and Intangible Assets 0000000.0470.0520000
Long Term Investments 000000000000
Tax Assets 000000000000
Other Non-Current Assets 000-0-00.1430.0960.0910.0550.1610.0640.009
Total Non-Current Assets 0.3350.5280.3580.5530.0210.573.5673.5612.8221.6050.2040.016
Total Assets 59.3977.00867.19830.8914.49136.22192.621110.914134.09317.0478.7340.164
Liabilities & Equity:
Current Liabilities:
Account Payables 6.9831.2191.3091.4151.1980.3994.3693.4712.5842.0461.0870
Short Term Debt 4.2220.2880.2590.12003.0750-0.3130.26500.172
Tax Payables 000000000000
Deferred Revenue 0000000.0250.0070.034-0.26500.007
Other Current Liabilities 2.4258.3142.1881.7351.5965.9825.4223.2143.71.5820.6913.341
Total Current Liabilities 13.639.8213.7563.272.7946.38212.8676.6858.593.8931.7883.521
Non-Current Liabilities:
Long Term Debt 19.62923.1850.2310.4900.0317.38314.9533.0252.52800.027
Deferred Revenue Non-Current 000000000000
Deferred Tax Liabilities Non-Current 000000000000
Other Non-Current Liabilities 000000.29100038.4622.2950
Total Non-Current Liabilities 19.62923.1850.2310.4900.32117.38314.9533.02540.98722.2950.027
Total Liabilities 33.25933.0063.9873.7612.7946.38230.2521.63811.61544.8824.0833.548
Equity:
Preferred Stock 000000000004.266
Common Stock 0.0110.010.0090.0070.0020.0110.010.010.010.0010.0010.001
Retained Earnings -144.501-101.558-60.704-43.785-28.938-192.816-151.948-101.075-62.254-29.819-16.037-8.077
Accumulated Other Comprehensive Income/Loss 00000-0.452-0.305-0.122-0.091-0.038-0.0070
Other Total Stockholders Equity 170.621145.55123.90570.90740.634222.645214.309190.342184.7222.0230.6930.426
Total Shareholders Equity 26.13144.00263.2127.1311.69829.83962.37189.277122.478-27.834-15.35-3.384
Total Equity 26.13144.00263.2127.1311.69829.83962.37189.277122.478-27.834-15.35-3.384
Total Liabilities & Shareholders Equity 59.3977.00867.19830.8914.49136.22192.621110.914134.09317.0478.7340.164